Your Impact – Fall 2021
October 19, 2021 – With the help of generous donors like you, we are improving the health and well-being of dogs, cats, horses and wildlife around the world.
Displaying 241 - 250 of 441 results
Celebrating 10 Years of the Golden Retriever Lifetime Study
August 4, 2022 – One of the largest studies ever conducted in veterinary medicine reaches its tenth year. Get an update on the Golden Retriever Lifetime Study!
Evaluating a Combination Therapy Approach for Oral Cancer in Cats
SUMMARY: Researchers will investigate the safety and anticancer effects of a new combination of radiation and drug therapy for treating cats with oral squamous cell carcinoma, one of the most...
Is Genetic Testing a Good Idea for Your Dog?
April 13, 2017 – Learn about dog DNA testing and how they can learn about your dog's ancestry or find markers of genetic diseases
Top Animal Health Findings 2024
December 5, 2024 – The end of the year is a good time to reflect on the achievements of the past year. It’s been an exciting one at the Foundation and we wanted to recap a few of the most impactful findings of 2024.
Do You Know the Top Ten Toxins in Dogs and Cats?
March 17, 2022 – Toxins pose an ever-present danger for our pets. Learn more about common toxins, exposure trends and what you can do to protect your pet.
Veterinary Student Scholars – What We Are Funding & Why
January 18, 2022 – Our Veterinary Student Scholar introduces students to research as a possible career path. In 2021, the Foundation funded 16 new projects.
Berkeley Springs’ Deb Nash Selected as Morris Animal Foundation Golden Retriever Lifetime Study Volunteer of the Year
DENVER/July 9, 2018 – Morris Animal Foundation is
60+ Years of Helping Horses Live Longer, Healthier Lives
July 7, 2023 — Morris Animal Foundation funds diagnostics, treatments and preventives for diseases, including cancer and foal pneumonia, and disorders, including equine metabolic syndrome, in horses.
Developing a Way to Predict Length of Disease-Free Intervals for Dogs with Bone Cancer
This study investigates how cytogenetic changes in canine osteosarcoma affect the duration of disease-free interval when patients are treated with amputation followed by doxorubicin and non-cytotoxic suramin.